id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1997-N-0011-0049,FDA,FDA-1997-N-0011,"Supporting Statement re OMB Information Collection Supporting Statement: Human Cells, Tissues, and Cellular and Tissue-Based Products; Establishment Registration and Listing OMB #0910-0469",Supporting & Related Material,Statement (Supporting and Related Material),2010-09-10T04:00:00Z,2010,9,,,2017-08-08T15:36:37Z,,0,0,09000064805c9af8
FDA-1997-N-0011-0048,FDA,FDA-1997-N-0011,"Notice of Approval re Agency Information Collection Activities; Announcement of OMB Approval; Human Cells, Tissues, and Cellular and Tissue-Based Products; Establishment Registration and Listing",Notice,Notice of Approval,2010-09-10T04:00:00Z,2010,9,2010-09-10T04:00:00Z,,2016-01-14T18:21:47Z,,0,0,09000064805c9af9
FDA-1997-N-0011-0047,FDA,FDA-1997-N-0011,"Notice of Final Rule re Human Cells, Tissues, and Cellular and Tissue-Based Products; Establishment Registration and Listing",Rule,Final Rule,2010-09-10T04:00:00Z,2010,9,2010-09-10T04:00:00Z,,2016-01-14T18:25:10Z,,0,0,09000064805c9af7
FDA-1997-N-0011-0051,FDA,FDA-1997-N-0011,"Notice of Confirmation of Effective Date re Human Cells, Tissues, and Cellular and Tissue-Based Products; Establishment Registration and Listing",Notice,Notice of Confirmation of Effective Date,2010-09-10T04:00:00Z,2010,9,2010-09-10T04:00:00Z,,2016-01-14T18:17:12Z,,0,0,09000064805c9afb
FDA-1997-N-0011-0044,FDA,FDA-1997-N-0011,Notice of Approval re Agency Information Collection Activities; Announcement of OMB Approval; Establishment Registration and Listing for Manufacturers of Human Cellular and Tissue-Based Products,Notice,Notice of Approval,2010-09-09T04:00:00Z,2010,9,2010-09-09T04:00:00Z,,2016-01-14T18:40:12Z,,0,0,09000064805c9af4
FDA-1997-N-0011-0045,FDA,FDA-1997-N-0011,Reply Statement re Supporting Statement for Establishment Registration and Listing for Manufacturers of Human Cellular and Tissue-Based Products OMB No. 0910-0372,Other,Reply,2010-09-09T04:00:00Z,2010,9,2010-09-09T04:00:00Z,,2016-01-15T17:10:06Z,,0,0,09000064805c9af3
FDA-1997-N-0011-0033,FDA,FDA-1997-N-0011,"Reference 2 - ""Letter from the Northwest Tissue Center to FDA dated December 4, 1995"" - [Establishment Registration and Listing for Manufacturers of Human Cellular and Tissue-Based Products; Proposed Rule; Reopening of Comment Period] re: FDA-1997-N-0011-0030",Supporting & Related Material,Background Material,2010-09-09T04:00:00Z,2010,9,,,2016-01-14T18:43:09Z,,0,0,0900006480b39507
FDA-1997-N-0011-0030,FDA,FDA-1997-N-0011,Notice of Proposed Rule; Reopening of Comment Period re Establishment Registration and Listing for Manufacturers of Human Cellular and Tissue-Based Products,Notice,General Notice,2010-09-09T04:00:00Z,2010,9,2010-09-09T04:00:00Z,1999-02-09T04:59:59Z,2016-01-15T15:11:39Z,,0,0,09000064805c9aec
FDA-1997-N-0011-0032,FDA,FDA-1997-N-0011,"Reference 1 - ""Letter from the American Red Cross to FDA dated November 14, 1995"" - [Establishment Registration and Listing for Manufacturers of Human Cellular and Tissue-Based Products; Proposed Rule; Reopening of Comment Period] re: FDA-1997-N-0011-0030",Supporting & Related Material,Background Material,2010-09-09T04:00:00Z,2010,9,,,2016-01-14T18:27:36Z,,0,0,0900006480b3947f
FDA-1997-N-0011-0034,FDA,FDA-1997-N-0011,"Reference 3 - ""Transcript of Meeting - Proposed Approach to Regulation of Cellular and Tissue-Based Products, March 17, 1997"" - [Establishment Registration and Listing for Manufacturers of Human Cellular and Tissue-Based Products; Proposed Rule; Reopening of Comment Period] re: FDA-1997-N-0011-0030",Supporting & Related Material,Background Material,2010-09-09T04:00:00Z,2010,9,,,2016-01-14T18:45:54Z,,0,0,0900006480b39508
FDA-1997-N-0011-0031,FDA,FDA-1997-N-0011,Background Information re Index of Supporting Documents - [Establishment Registration and Listing for Manufacturers of Human Cellular and Tissue-Based Products; Proposed Rule; Reopening of Comment Period] re: FDA-1997-N-0011-0030,Supporting & Related Material,Background Material,2010-09-09T04:00:00Z,2010,9,,,2016-01-14T16:58:29Z,,0,0,0900006480b3947d
FDA-1997-N-0011-0027,FDA,FDA-1997-N-0011,Summary of Pilot Study of Tissue Establishment Registration and Listing,Other,Summary (SUM),2010-09-09T04:00:00Z,2010,9,2010-09-09T04:00:00Z,,2016-12-08T22:08:53Z,,0,0,09000064805c9ae9
FDA-1997-N-0011-0037,FDA,FDA-1997-N-0011,"Reference 7 - ""Transcript of Transmissible Spongiform Encephalopathies Advisory Committee Meeting - October 7, 1997"" - [Establishment Registration and Listing for Manufacturers of Human Cellular and Tissue-Based Products; Proposed Rule; Reopening of Comment Period] re: FDA-1997-N-0011-0030",Supporting & Related Material,BKG-Background Material,2010-09-09T04:00:00Z,2010,9,,,2016-01-15T20:40:32Z,,0,0,0900006480b395f8
FDA-1997-N-0011-0036,FDA,FDA-1997-N-0011,"Reference 6 - ""Transcript of Transmissible Spongiform Encephalopathies Advisory Committee Meeting - October 6, 1997"" - [Establishment Registration and Listing for Manufacturers of Human Cellular and Tissue-Based Products; Proposed Rule; Reopening of Comment Period] re: FDA-1997-N-0011-0030",Supporting & Related Material,BKG-Background Material,2010-09-09T04:00:00Z,2010,9,,,2016-01-15T20:45:38Z,,0,0,0900006480b395f7
FDA-1997-N-0011-0035,FDA,FDA-1997-N-0011,"Reference 4 - ""Meeting Between FDA and AATB regarding Demineralized Bone Matrix Regulation, July 11, 1997"" - [Establishment Registration and Listing for Manufacturers of Human Cellular and Tissue-Based Products; Proposed Rule; Reopening of Comment Period] re: FDA-1997-N-0011-0030",Supporting & Related Material,Background Material,2010-09-09T04:00:00Z,2010,9,,,2016-01-14T18:52:11Z,,0,0,0900006480b3950a
FDA-1997-N-0011-0026,FDA,FDA-1997-N-0011,"FDA/CBER  Response Letter dated April 30, 1998",Other,Letter(s),2010-09-09T04:00:00Z,2010,9,2010-09-09T04:00:00Z,,2016-12-08T22:10:22Z,,0,0,09000064805c9ae8
FDA-1997-N-0011-0008,FDA,FDA-1997-N-0011,Request for Extension re Comment from Heller Ehrman White & McAuliffe,Other,Request for Extension,2010-09-07T04:00:00Z,2010,9,2010-09-02T04:00:00Z,1998-08-13T03:59:59Z,2016-12-09T15:43:48Z,,0,0,09000064805c9ad6
FDA-1997-N-0011-0004,FDA,FDA-1997-N-0011,Reference re Establishment Registration and Listing for Manufacturers of Human Cellular and Tissue-Based Products,Supporting & Related Material,Reference (internal unless indicated),2010-09-02T04:00:00Z,2010,9,,,2016-12-09T15:47:50Z,,0,0,09000064805c9ad1
FDA-1997-N-0011-0003,FDA,FDA-1997-N-0011,Notice of Proposed Rulemaking re FDA Establishment Registration and Listing for Manufacturers of Human Cellular and Tissue-Based Products,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2010-09-02T04:00:00Z,2010,9,2010-09-02T04:00:00Z,1998-08-13T03:59:59Z,2016-12-09T15:46:51Z,,0,0,09000064805c9ad2
FDA-1997-N-0011-0002,FDA,FDA-1997-N-0011,"Notice of Correction re Human Cells, Tissues, and Cellular and Tissue-Based Products; Establishment Registration and Listing; Correction",Notice,Correction,2004-02-09T05:00:00Z,2004,2,2004-01-30T05:00:00Z,,2016-01-14T18:13:27Z,,0,0,09000064805c9afc
FDA-1997-N-0011-0001,FDA,FDA-1997-N-0011,"Notice of Final Rule re Human Cells, Tissues, and Cellular and Tissue-Based Products; Establishment Registration and Listing",Rule,Final Rule,2004-01-29T05:00:00Z,2004,1,2004-01-23T05:00:00Z,2004-04-27T03:59:59Z,2016-01-14T18:15:41Z,,0,0,09000064805c9acf